ENZYCHEM LIFESCIENCES CORPORATION

Company Description

We are a Global New Drug Development Company. We have EC-18, our leading compound to treat chemotherapy-induced neutropenia and thrombocytopenia. EC-18 is a non-protein small molecule and oral first-in-class drug as a supplemental drug for most cancer drugs.

We are a functional health food company. We have ROCKPID, the world's first patented immune-modulatory functional health food (FHF), which was approved by the Korean FDA in December 2013.

We also develop and manufacture generic APIs (active pharmaceutical ingredients) such as cephalosporin antibiotics, anti-tuberculosis, anti-coagulant, analgesic, and so on.

Company Information

• Country/Region: Korea
• Address: F741 KAIST-ICC, 193 Munji-ro
• Operational Address: 15F, Trust tower, 60, Mabang-ro, Seocho-gu, SEOUL, South Korea
• Website: http://www.enzychem.com/
• Business Type: Manufacturer, Buying Office, Distributor/Wholesale
• Main Products: D-Cycloserine, Terizidone, Erdosteine, Cefotiam, Cefazedone,
• Location: Daejeon, South Korea
• Year Established: 1999
• Year Start Exporting: 1999
• Number Of Employess: 51 - 100 People
• Trade Capacity: Accepted Delivery Terms : FOB, CFR, CIF, EXW, CIP,
• Production Capacity: No. of Production Lines : 5 Annual Output Value :
• R&D Capacity: No. of R&D Staff :11 - 20 People

Contact info

• Contact Person: Mr. Jake Lee
• Telephone:
• Zip/Post Code: 305-732